Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 26796981 |
BR |
72 | 1 |
Rheumatoid arthritis, Asthenia, Gait disturbance, Arthralgia, Pain in extremity, Back pain, Muscle spasms, Product dose omission issue, |
||||
LEFLUNOMIDE, |
||||
| 802 | 26797065 |
CA |
59 | 2 |
Hepatic cirrhosis, Hand deformity, Gait disturbance, Fatigue, Foot deformity, Exostosis, Grip strength decreased, General physical health deterioration, Infection, Incorrect route of product administration, Headache, Hepatic enzyme increased, Impaired healing, Helicobacter infection, Ill-defined disorder, Folliculitis, Hypertension, Hypoaesthesia, Hypercholesterolaemia, Hypersensitivity, Gait inability, Glossodynia, Epilepsy, Fibromyalgia, |
||||
DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, BUPIVACAINE HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, CAFFEINE CITRATE, |
||||
| 803 | 26797329 |
US |
2 | |
Brain oedema, Stress, Gait disturbance, |
||||
ASFOTASE ALFA, |
||||
| 804 | 26797353 |
US |
85 | 2 |
Fall, Gait disturbance, Impaired healing, |
||||
INSULIN LISPRO, |
||||
| 805 | 26797354 |
GB |
2 | |
Confusional state, Memory impairment, Fluid retention, Hypoaesthesia, Gait disturbance, Dizziness, Rash pruritic, |
||||
TIRZEPATIDE, |
||||
| 806 | 26797435 |
US |
60 | 2 |
Death, Platelet count decreased, Asthenia, Decreased appetite, Abdominal pain, Gait disturbance, Pain, |
||||
ECULIZUMAB, ECULIZUMAB, ECULIZUMAB, GABAPENTIN, RAMIPRIL, AMLODIPINE, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, CHLORTHALIDONE, IRON, |
||||
| 807 | 26797647 |
US |
73 | 2 |
Vision blurred, Dizziness, Dysgeusia, Nausea, Hypophagia, Tremor, Gait disturbance, |
||||
LENALIDOMIDE, BORTEZOMIB, DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 808 | 26798097 |
EU |
5 | 1 |
Myalgia, Arthralgia, Gait disturbance, |
||||
| 809 | 26798294 |
EU |
80 | 2 |
Cerebrovascular accident, Oropharyngeal discomfort, Restlessness, On and off phenomenon, Catheter site related reaction, Therapeutic product effect decreased, Catheter site bruise, Device difficult to use, Loss of personal independence in daily activities, Fluid intake reduced, Tremor, Gait disturbance, Muscle spasms, Injection site inflammation, Musculoskeletal stiffness, Injection site reaction, Product dose omission in error, Hypophagia, Anxiety, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, AMLODIPINE, CANDESARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PRAMIPEXOLE, |
||||
| 810 | 26793020 |
US |
2 | |
Gait disturbance, Mobility decreased, Eye pain, Nasal polyps, Dermatitis atopic, Arthralgia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 811 | 26793161 |
US |
2 | |
Renal failure, Renal impairment, Dizziness, Sciatica, Vertigo, Gait disturbance, Decreased appetite, Weight decreased, Underweight, Dysstasia, Blood pressure decreased, Feeding disorder, Laboratory test abnormal, Rash, Nausea, Asthenia, Pruritus, |
||||
RAVULIZUMAB, |
||||
| 812 | 26793290 |
US |
49 | 1 |
Dry eye, Pain, Limb mass, Gait disturbance, Limb discomfort, |
||||
DUPILUMAB, |
||||
| 813 | 26793530 |
US |
2 | |
Gait disturbance, Shoulder operation, |
||||
EVOLOCUMAB, |
||||
| 814 | 26793546 |
US |
78 | |
Gait disturbance, Pain in extremity, Muscle spasms, |
||||
EVOLOCUMAB, |
||||
| 815 | 26793701 |
US |
70 | 2 |
Carpal tunnel syndrome, Injection site pruritus, Limb injury, Gait disturbance, Trigger finger, |
||||
RISANKIZUMAB-RZAA, |
||||
| 816 | 26792143 |
US |
1 | |
Dyspnoea, Chronic obstructive pulmonary disease, Fatigue, Gait disturbance, |
||||
IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 817 | 26792330 |
US |
78 | 1 |
Brain fog, Speech disorder, Gait disturbance, |
||||
| 818 | 26792359 |
US |
79 | 1 |
Gait disturbance, Tremor, Visual impairment, Product substitution issue, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 819 | 26792370 |
US |
||
Feeling abnormal, Therapeutic response shortened, Fatigue, Gait disturbance, Dyskinesia, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, AMANTADINE, |
||||
| 820 | 26792379 |
US |
||
Gait disturbance, Feeling hot, Loss of personal independence in daily activities, Drug intolerance, Anxiety, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 821 | 26787165 |
BR |
71 | 2 |
Gastrointestinal infection, Gait disturbance, Psoriasis, Purulence, Abscess, |
||||
| 822 | 26787406 |
76 | ||
Rheumatoid arthritis, Knee operation, Lower limb fracture, Fall, Limb operation, Thrombosis, Gait disturbance, Postoperative wound complication, Procedural pain, Pain in extremity, Back pain, Incorrect dose administered, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, BISOPROLOL FUMARATE, CALCIUM, |
||||
| 823 | 26787840 |
US |
57 | 1 |
Cardiac failure, Weight decreased, Atrial fibrillation, Hernia repair, Gait disturbance, Pain, |
||||
SOMATROPIN, |
||||
| 824 | 26787868 |
US |
||
Application site swelling, Application site erythema, Arthralgia, Contusion, Condition aggravated, Gait disturbance, |
||||
DICLOFENAC SODIUM, |
||||
| 825 | 26787899 |
US |
79 | 1 |
Hallucination, Gait disturbance, Confusional state, Oedema peripheral, |
||||
PIMAVANSERIN TARTRATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, FINASTERIDE, FOSINOPRIL, MEMANTINE, MEMANTINE HYDROCHLORIDE, QUETIAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 826 | 26788186 |
24 | ||
Somnolence, Gait disturbance, Diarrhoea, Seizure, Balance disorder, Apathy, Feeling abnormal, Depressed mood, Fall, Fatigue, |
||||
FENFLURAMINE, |
||||
| 827 | 26788496 |
US |
2 | |
Brain neoplasm, Deep vein thrombosis, Urinary retention, Gallbladder operation, Hypersensitivity, Arthritis, Nervous system disorder, Psoriasis, Gait disturbance, Gastrooesophageal reflux disease, Wrong technique in product usage process, Gastrointestinal disorder, |
||||
APREMILAST, APREMILAST, ETANERCEPT, ETANERCEPT, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 828 | 26788754 |
US |
76 | 2 |
Lumbar vertebral fracture, Gait disturbance, Pain, |
||||
DUPILUMAB, |
||||
| 829 | 26788887 |
US |
90 | 2 |
Blindness, Hypersomnia, Rectal haemorrhage, Visual impairment, Gait disturbance, Haemorrhoids, Injury, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, FAMOTIDINE, ERGOCALCIFEROL, |
||||
| 830 | 26789573 |
US |
2 | |
Gait disturbance, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 831 | 26789592 |
US |
12 | 2 |
Mobility decreased, Dermatitis acneiform, Gait disturbance, Peripheral swelling, Pain in extremity, Arthralgia, Joint swelling, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 832 | 26789824 |
US |
47 | 1 |
Gait disturbance, Dysstasia, Restlessness, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 833 | 26790153 |
88 | 1 | |
Heart rate decreased, Dyspepsia, Head discomfort, Sensation of foreign body, Gait disturbance, Cough, Tremor, Malaise, Loss of consciousness, Product dose omission issue, Intentional product use issue, |
||||
RIOCIGUAT, |
||||
| 834 | 26790307 |
US |
78 | |
Fatigue, Pain in extremity, Dyspnoea, Asthenia, Gait disturbance, Hypersensitivity, |
||||
VUTRISIRAN, TAFAMIDIS, DAROLUTAMIDE, CHLORTHALIDONE, |
||||
| 835 | 26790689 |
US |
||
Chronic kidney disease, Nephrocalcinosis, Bone pain, Myalgia, Gait disturbance, Hypertension, Poor dental condition, |
||||
ASFOTASE ALFA, |
||||
| 836 | 26790717 |
US |
61 | 1 |
Cutaneous T-cell lymphoma, Dermatitis exfoliative generalised, Neurodermatitis, Skin exfoliation, Weight decreased, Skin hypertrophy, Drug ineffective, Arthralgia, Rash pruritic, Skin discolouration, Dermatitis, Pain in extremity, Gait disturbance, Dyspnoea exertional, White blood cell count increased, Peripheral swelling, Limb discomfort, Oedema, Joint stiffness, Eczema, Skin hyperplasia, |
||||
ZOLPIDEM TARTRATE, ALBUTEROL SULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DUPILUMAB, AMLODIPINE, ALLOPURINOL, AMMONIUM LACTATE, MUPIROCIN, MUPIROCIN CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, RIVAROXABAN, PREDNISONE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, LORATADINE, LORATADINE ORAL, INDOMETHACIN, CETIRIZINE HCL, CETIRIZINE, LOSARTAN, HYDROCHLOROTHIAZIDE, GABAPENTIN, GABAPENTIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, METHYLPREDNISOLONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MONTELUKAST SODIUM, MONTELUKAST, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, BUMETANIDE, FUROSEMIDE, |
||||
| 837 | 26791006 |
US |
||
Deafness bilateral, Asthma, Pain in extremity, Fatigue, Osteopenia, Gait disturbance, Injection site discolouration, Injection site calcification, Injection site atrophy, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
| 838 | 26791313 |
US |
2 | |
Nausea, Vomiting, Arthralgia, Limb injury, Back pain, Musculoskeletal stiffness, Decreased appetite, Tooth disorder, Gait disturbance, Blood albumin increased, Blood bilirubin increased, Blood alkaline phosphatase decreased, Protein total increased, |
||||
ASFOTASE ALFA, |
||||
| 839 | 26791653 |
EU |
83 | |
Gait disturbance, Pyrexia, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHYLPREDNISOLONE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, TAMSULOSIN HYDROCHLORIDE, SERTRALINE, AZITHROMYCIN DIHYDRATE, |
||||
| 840 | 26791956 |
US |
2 | |
Tendon rupture, Skin laceration, Gait disturbance, Acne, Foot deformity, Eczema, Concussion, Thermal burn, Headache, Dermatitis atopic, Eye contusion, |
||||
UPADACITINIB, UPADACITINIB, MAGNESIUM, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, FAMOTIDINE, ERGOCALCIFEROL, MELOXICAM, MELOXICAM, GABAPENTIN, GABAPENTIN, METHOCARBAMOL, |
||||
| 841 | 26782221 |
US |
75 | 1 |
Condition aggravated, Gait disturbance, |
||||
SARILUMAB, |
||||
| 842 | 26782599 |
EU |
68 | |
Syncope, Gait disturbance, |
||||
LIRAGLUTIDE, INSULIN GLARGINE, PREGABALIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, RAMIPRIL, |
||||
| 843 | 26782777 |
US |
2 | |
Muscle rupture, Gait disturbance, Pain in extremity, |
||||
EVOLOCUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 844 | 26782962 |
US |
2 | |
Dyspnoea, Gait disturbance, |
||||
AMBRISENTAN, FUROSEMIDE, COLCHICINE, SILDENAFIL CITRATE, SILDENAFIL, PREDNISONE, SPIRONOLACTONE, WARFARIN SODIUM, WARFARIN, AMIODARONE HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, OMEPRAZOLE MAGNESIUM, TREPROSTINIL, |
||||
| 845 | 26783028 |
CA |
40 | 1 |
Tendon pain, Arthralgia, Gait disturbance, Pain in extremity, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 846 | 26783266 |
CA |
59 | 2 |
Arthrodesis, Gait disturbance, Pain, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 847 | 26783327 |
US |
28 | 1 |
Diarrhoea, Headache, Leukocytosis, Drooling, Dysarthria, Confusional state, Gait disturbance, Oxygen saturation decreased, |
||||
CLOZAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LITHIUM, LITHIUM BROMATUM, DIVALPROEX SODIUM, PROPRANOLOL HYDROCHLORIDE, VALPROIC ACID, |
||||
| 848 | 26783506 |
CA |
72 | 2 |
Back pain, Blood creatinine increased, Deafness, Disease progression, Disease recurrence, Bursitis, Dry mouth, Electric shock sensation, Feeling abnormal, Gait disturbance, Glomerular filtration rate decreased, Arthralgia, Inflammatory marker increased, Joint swelling, Hypoaesthesia, Limb discomfort, Movement disorder, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Nerve compression, Pain, Pain in extremity, Pain in jaw, Paraesthesia, Polyarthritis, Drug intolerance, Tinnitus, Hypersensitivity, Tachycardia, Inflammation, Adverse event, Headache, |
||||
DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LOSARTAN POTASSIUM, LOSARTAN, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 849 | 26783554 |
EU |
43 | 2 |
Multiple sclerosis, Feeling hot, Drug dependence, Accidental overdose, Drug ineffective, Crying, Walking disability, Exercise tolerance decreased, Cystitis noninfective, Choking sensation, Thyroid mass, Dysaesthesia, Bladder dysfunction, Inflammatory marker increased, Neuralgia, Malaise, Muscle tightness, Flushing, Toothache, Tremor, Gait disturbance, Vision blurred, Fear of falling, Anxiety, Micturition urgency, Back pain, Seasonal allergy, Headache, Muscle spasticity, Abdominal discomfort, Nasopharyngitis, Cardiac disorder, Panic attack, Hypoaesthesia, Nasopharyngitis, Burning sensation, Fatigue, Muscle spasms, Dizziness, Palpitations, Dysmenorrhoea, Nausea, Hypertension, Initial insomnia, Musculoskeletal stiffness, Discomfort, Blood pressure increased, Arthralgia, Facial pain, Neuropathy peripheral, Pain, Feeling abnormal, Circulatory collapse, Foreign body in eye, Pneumonia, COVID-19, Dyspnoea, Decreased appetite, Diarrhoea, Otitis media, Tachycardia, Malaise, Micturition urgency, Burning sensation, Asthenia, |
||||
PREGABALIN, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ENALAPRIL, ENALAPRIL, ENALAPRIL, |
||||
| 850 | 26783574 |
CA |
43 | 2 |
Epilepsy, Depression, Irritable bowel syndrome, Product quality issue, Wound infection, Back injury, Inflammation, Systemic lupus erythematosus, Therapeutic product effect decreased, Glossodynia, Muscle spasms, Vomiting, Pain, Arthropathy, Nail disorder, Blood cholesterol increased, Infusion related reaction, Confusional state, Rheumatoid arthritis, Urticaria, Intentional product use issue, Therapeutic product effect incomplete, Injury, Impaired healing, Lung disorder, Abdominal discomfort, Nasopharyngitis, Nausea, Weight increased, Muscle injury, Hepatic enzyme increased, Pain in extremity, Obesity, Peripheral swelling, Drug intolerance, Dizziness, Swelling, Pneumonia, Pericarditis, Blister, Asthenia, Liver injury, Taste disorder, Bursitis, Joint range of motion decreased, Anti-cyclic citrullinated peptide antibody positive, Facet joint syndrome, Live birth, Lip dry, Gastrooesophageal reflux disease, Dry mouth, Folliculitis, Osteoarthritis, Drug hypersensitivity, Contraindicated product administered, Joint swelling, Infusion site reaction, Hypertension, Breast cancer stage III, General physical health deterioration, C-reactive protein increased, Musculoskeletal pain, Gait inability, Rheumatic fever, Blepharospasm, Stomatitis, Liver function test increased, Alopecia, Sleep disorder, Duodenal ulcer perforation, Hypercholesterolaemia, Muscular weakness, Synovitis, Abdominal pain upper, Helicobacter infection, Diarrhoea, Drug ineffective, Psoriatic arthropathy, Peripheral venous disease, Night sweats, Arthralgia, Lower respiratory tract infection, Onychomadesis, Paraesthesia, Maternal exposure during pregnancy, Product use in unapproved indication, Pemphigus, Rash, Mobility decreased, Wound, Hand deformity, Type 2 diabetes mellitus, Product use issue, Neck pain, Hypoaesthesia, Memory impairment, Treatment failure, Fibromyalgia, Migraine, Off label use, Liver disorder, Discomfort, Infection, Headache, Rheumatoid factor positive, Pruritus, Anxiety, Oedema, Decreased appetite, Lower limb fracture, Malaise, Fatigue, Gastrointestinal disorder, Hypersensitivity, Dyspnoea, Disability, Insomnia, Breast cancer stage II, Dislocation of vertebra, Adjustment disorder with depressed mood, Ear pain, Grip strength decreased, Delirium, Condition aggravated, Respiratory disorder, Amnesia, Normal newborn, Swollen joint count increased, Pregnancy, Pyrexia, Wheezing, Road traffic accident, Walking aid user, Weight decreased, X-ray abnormal, Prescribed overdose, Sinusitis, Therapy non-responder, C-reactive protein abnormal, Musculoskeletal stiffness, Sciatica, Gait disturbance, Autoimmune disorder, Asthma, C-reactive protein, Chest pain, Contusion, Deep vein thrombosis postoperative, Ill-defined disorder, Knee arthroplasty, Exposure during pregnancy, Sleep disorder due to a general medical condition, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, MINOCYCLINE, MEPOLIZUMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, VITAMIN C, TRETINOIN, BOTULINUM TOXIN TYPE A, PHENYLEPHRINE, PHENYLEPHRINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, RAMIPRIL, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PHOSPHORUS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, CORTISONE ACETATE, CORTISONE ACETATE, BUPRENORPHINE, FLUTICASONE PROPIONATE, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, ABATACEPT, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE, RANITIDINE, USTEKINUMAB, CELECOXIB, CELECOXIB, CELECOXIB, MAGNESIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, GOLIMUMAB, CYCLOBENZAPRINE, APREMILAST, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SARILUMAB, INFLIXIMAB, TOFACITINIB, TOFACITINIB, PANTOPRAZOLE, ERENUMAB-AOOE, ERENUMAB-AOOE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, CANDESARTAN, CANDESARTAN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CHLORHEXIDINE GLUCONATE, RITUXIMAB-ARRX, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ABATACEPT, ABATACEPT, SARILUMAB, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ATOMOXETINE HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SECUKINUMAB, MELOXICAM, MELOXICAM, |
||||
| 851 | 26783721 |
US |
1 | |
Asthenia, Gait disturbance, Fatigue, Pain in extremity, Muscular weakness, Weight increased, Therapy interrupted, |
||||
VAMOROLONE, VAMOROLONE, VAMOROLONE, VAMOROLONE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 852 | 26783868 |
CN |
57 | 2 |
Insomnia, Palmar-plantar erythrodysaesthesia syndrome, Muscular weakness, Gait disturbance, Sleep disorder, |
||||
CAPECITABINE, |
||||
| 853 | 26784060 |
CA |
2 | |
Gait disturbance, Arthralgia, Product dose omission issue, |
||||
SOMATROPIN, |
||||
| 854 | 26784174 |
US |
1 | |
Condition aggravated, Gait disturbance, Foot deformity, |
||||
RISANKIZUMAB-RZAA, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMMONIUM LACTATE, CLINDAMYCIN HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, CETIRIZINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, LISINOPRIL, AMLODIPINE BESYLATE, |
||||
| 855 | 26784351 |
US |
1 | |
General physical health deterioration, Gait disturbance, |
||||
VAMOROLONE, VAMOROLONE, LISINOPRIL, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 856 | 26784787 |
EU |
56 | 2 |
Carotid artery stenosis, Subclavian artery stenosis, Vertebrobasilar artery stenosis, Nocturnal dyspnoea, Carotid bruit, Carotid arteriosclerosis, Arterial flow velocity decreased, Carotid intima-media thickness increased, Vasculitis, Vertebrobasilar artery stenosis, Internal carotid artery deformity, Drug intolerance, Vertebral artery hypoplasia, Myalgia, Arthralgia, Gait disturbance, Remission not achieved, Carotid artery occlusion, Cerebral artery stenosis, |
||||
IMATINIB, IMATINIB, IMATINIB, NILOTINIB, NILOTINIB, NILOTINIB, HYDROXYUREA, OLANZAPINE, OLANZAPINE, |
||||
| 857 | 26784874 |
BR |
72 | 2 |
Asthenia, Hypotension, Gait disturbance, Pain, Back pain, Pain in extremity, Fatigue, Diarrhoea, Taste disorder, Weight decreased, Loss of personal independence in daily activities, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 858 | 26784942 |
EU |
55 | 2 |
Myalgia, Gait disturbance, |
||||
ROSUVASTATIN, ROSUVASTATIN CALCIUM, SIMVASTATIN, EZETIMIBE, |
||||
| 859 | 26785260 |
EU |
68 | 2 |
Pain in extremity, Injection site pain, Limb discomfort, Myalgia, Muscle contracture, Gait disturbance, Muscle atrophy, Wrong technique in product usage process, |
||||
GLATIRAMER ACETATE, |
||||
| 860 | 26785312 |
GB |
61 | 2 |
Dyspnoea, Medication error, Hypertension, Heart rate irregular, Eye contusion, Hot flush, Flushing, Hypoaesthesia, Pain, Peripheral swelling, Gait disturbance, Fatigue, Peripheral vascular disorder, Peripheral coldness, |
||||
| 861 | 26785347 |
GB |
2 | |
Arthralgia, Asthenia, Gait disturbance, Movement disorder, Malaise, |
||||
GABAPENTIN, |
||||
| 862 | 26785696 |
EU |
65 | |
Haematochezia, Haematochezia, Urinary tract infection, Urinary tract infection, Acne, Acne, Rash, Rash, Feeling of relaxation, Gait disturbance, Balance disorder, |
||||
RUXOLITINIB, RUXOLITINIB, PANTOPRAZOLE, |
||||
| 863 | 26785704 |
AU |
1 | |
Cerebellar stroke, Cerebral hypoperfusion, Neuropathy peripheral, Abdominal distension, Balance disorder, Binocular eye movement disorder, Depression, Diplopia, Dysarthria, Dysphonia, Feeling cold, Frustration tolerance decreased, Gait disturbance, Hyporesponsive to stimuli, Hypotension, Micturition urgency, Neuralgia, Nocturia, On and off phenomenon, Presyncope, Speech disorder, Constipation, Dizziness, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PREGABALIN, RABEPRAZOLE SODIUM, RABEPRAZOLE, RIVAROXABAN, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, APOMORPHINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, AMANTADINE HYDROCHLORIDE, CARBIDOPA, CARBIDOPA TABLETS, FUROSEMIDE, NORTRIPTYLINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, RASAGILINE MESYLATE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, RIVAROXABAN, |
||||
| 864 | 26786047 |
EU |
1 | |
Memory impairment, Dementia, Loss of personal independence in daily activities, Transient global amnesia, Gait disturbance, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 865 | 26786092 |
US |
73 | 2 |
Death, Interstitial lung disease, Osteoarthritis, Activities of daily living decreased, Gait disturbance, Gastrooesophageal reflux disease, Laryngitis, Cough, Back pain, Antinuclear antibody positive, Exercise tolerance decreased, |
||||
ESOMEPRAZOLE MAGNESIUM, TOFACITINIB, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MAGNESIUM OXIDE, LORATADINE, LORATADINE TABLET, OXYGEN, 0XYGEN, FAMOTIDINE, PANTOPRAZOLE, CALCIUM, EMPAGLIFLOZIN, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LOSARTAN, |
||||
| 866 | 26786102 |
US |
1 | |
Neurological symptom, Gait disturbance, Fall, Balance disorder, Vision blurred, Road traffic accident, Memory impairment, Product dose omission in error, |
||||
OSIMERTINIB, |
||||
| 867 | 26786138 |
US |
84 | 2 |
Cognitive disorder, Overdose, Weight decreased, Insomnia, Drug ineffective, Gait disturbance, Coma, Paralysis, Mental impairment, Parkinsonism, Incontinence, Delirium, Tardive dyskinesia, Off label use, Product prescribing error, Adverse reaction, |
||||
VILAZODONE HYDROCHLORIDE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, GABAPENTIN, CLONAZEPAM, DONEPEZIL HYDROCHLORIDE, |
||||
| 868 | 26786614 |
JP |
59 | 2 |
Movement disorder, Gait disturbance, |
||||
TISOTUMAB VEDOTIN, SULFASALAZINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, |
||||
| 869 | 26786757 |
46 | 2 | |
Hemiparesis, Malignant neoplasm progression, Central nervous system lesion, Pulmonary fibrosis, Decreased appetite, Peripheral swelling, Speech disorder, Gait disturbance, Joint swelling, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 870 | 26786883 |
CN |
29 | |
Hyperthyroidism, Lymphadenopathy, Asthenia, Tinnitus, Nasal obstruction, Sensation of foreign body, Dry mouth, Dysgeusia, Temperature intolerance, Peripheral coldness, Muscular weakness, Hyperhidrosis, Diarrhoea, Decreased appetite, Poor quality sleep, Myalgia, Gait disturbance, Oropharyngeal erythema, Pharyngeal swelling, Pharyngeal inflammation, Tonsillar inflammation, Lymph node pain, Monocyte count increased, Lymphocyte count decreased, Upper respiratory tract infection, Product use in unapproved indication, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 871 | 26786964 |
EU |
31 | 2 |
Extrapyramidal disorder, Dyskinesia, Gait disturbance, |
||||
PALIPERIDONE, |
||||
| 872 | 26790301 |
47 | 2 | |
Chest pain, Headache, Tremor, Photophobia, Musculoskeletal stiffness, Gait disturbance, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, |
||||
| 873 | 26776440 |
US |
78 | 1 |
Blood potassium decreased, Urinary tract infection, Blood magnesium decreased, Facial paralysis, Malaise, Vitamin B12 decreased, Fatigue, Speech disorder, Balance disorder, Gait disturbance, Unevaluable event, Infusion site swelling, Infusion site erythema, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CLOPIDOGREL, ALPRAZOLAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CARBIDOPA AND LEVODOPA, DICYCLOMINE HYDROCHLORIDE, GABAPENTIN, PSYLLIUM HUSK, PANTOPRAZOLE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FLUDROCORTISONE ACETATE, POLYETHYLENE GLYCOL 3350, LINACLOTIDE, HYDRALAZINE HYDROCHLORIDE, |
||||
| 874 | 26776477 |
US |
46 | 2 |
Fatigue, Gait disturbance, Nasopharyngitis, |
||||
DIROXIMEL FUMARATE, |
||||
| 875 | 26776504 |
CA |
43 | |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug intolerance, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Contraindicated product administered, Off label use, Overdose, Suspected off label use, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, USTEKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, APREMILAST, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 876 | 26776744 |
EG |
51 | 1 |
Neuropathy peripheral, Hypoaesthesia, Gait disturbance, Fall, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 877 | 26776854 |
US |
52 | |
Headache, Arthralgia, Influenza like illness, Gait disturbance, |
||||
| 878 | 26776964 |
US |
1 | |
Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 879 | 26777069 |
US |
81 | 1 |
Foot deformity, Fall, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, CARBIDOPA AND LEVODOPA, |
||||
| 880 | 26777118 |
US |
51 | 1 |
Back pain, Gait disturbance, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 881 | 26777487 |
US |
2 | |
Pulmonary thrombosis, Thrombosis, Cardiac ventricular thrombosis, Gait disturbance, |
||||
OLAPARIB, |
||||
| 882 | 26777726 |
EU |
56 | 1 |
Mobility decreased, Delirium, General physical health deterioration, Lymphadenopathy, Gait disturbance, Disorientation, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, PRAMIPEXOLE, |
||||
| 883 | 26777911 |
US |
70 | 2 |
Melaena, Coma, Peripheral swelling, Oedema, Skin discolouration, Gait disturbance, Urinary incontinence, Myalgia, Hypoaesthesia, Rash macular, Paraesthesia, Device related infection, |
||||
ATENOLOL, |
||||
| 884 | 26778023 |
BR |
2 | |
Pneumonia, Pneumonia bacterial, Obstructive airways disorder, Pneumonia, Anaemia, Asthenia, Dyspnoea, Weight decreased, Insomnia, Fatigue, Fatigue, Diarrhoea, Hyperthyroidism, Hypothyroidism, Metastases to spine, Metastases to bone, Nervousness, Back pain, Renal injury, Blood pressure decreased, Angina pectoris, Abdominal discomfort, Abdominal pain, Allergic cough, Anaemia, Abdominal discomfort, Blood pressure increased, Blood pressure abnormal, Cardiovascular disorder, Cough, Crying, Contusion, Decreased immune responsiveness, Drug intolerance, Decreased immune responsiveness, Decreased immune responsiveness, Decreased immune responsiveness, Decreased immune responsiveness, Dyskinesia, Eating disorder, Ecchymosis, Feeding disorder, Feeding disorder, Gait disturbance, Head discomfort, Hypotension, Hypoacusis, Root canal infection, Influenza, Influenza, Influenza, Muscle spasms, Musculoskeletal stiffness, Memory impairment, Muscular weakness, Musculoskeletal chest pain, Musculoskeletal chest pain, Memory impairment, Nasopharyngitis, Neuralgia, Nodule, Pain in extremity, Pain in extremity, Presyncope, Palpitations, Palpitations, Parosmia, Peripheral swelling, Platelet count decreased, Pulpitis dental, Pyrexia, Renal disorder, Retching, Sensitivity to weather change, Tooth disorder, Vertigo, Vision blurred, Vitamin D decreased, Anaemia, Asthenia, Bone pain, Chest pain, Constipation, Diarrhoea, Dizziness, Dry mouth, Dyspnoea, Headache, Insomnia, Malaise, Malaise, Myalgia, Nausea, Pain, Pain, Pain, Somnolence, Vomiting, Vomiting, Vomiting, Weight increased, Product prescribing error, Product use issue, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, EXEMESTANE, AMOXICILLIN, MORPHINE, MORPHINE, MORPHINE, MORPHINE, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 885 | 26778071 |
CN |
18 | 2 |
Folate deficiency, Haemoglobin decreased, Gait disturbance, Red blood cell count decreased, |
||||
OXCARBAZEPINE, |
||||
| 886 | 26778075 |
GB |
66 | 2 |
Pruritus, Fatigue, Paraesthesia oral, Diarrhoea, Abdominal distension, Muscular weakness, Pain, Palpitations, Gait disturbance, Abdominal pain upper, Insomnia, |
||||
ZOLEDRONIC ACID, |
||||
| 887 | 26778113 |
US |
||
Gait disturbance, Pain in extremity, Drug ineffective, Pain, Swelling, Musculoskeletal stiffness, Peripheral swelling, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 888 | 26778306 |
US |
79 | 1 |
Pneumonia, Aspiration, Atrioventricular block, Gait disturbance, Pyrexia, Heart rate abnormal, |
||||
DUPILUMAB, |
||||
| 889 | 26778802 |
AU |
2 | |
Thoracic vertebral fracture, Rib fracture, Drug ineffective, Peripheral swelling, Pain, Asthenia, Muscular weakness, Gait disturbance, |
||||
DENOSUMAB, ERGOCALCIFEROL, CALCIUM, PROPRANOLOL HYDROCHLORIDE, ESTRIOL0.2%, ESTRIOL, |
||||
| 890 | 26779517 |
US |
2 | |
Headache, Back pain, Diarrhoea, Pain in extremity, Gait disturbance, Musculoskeletal disorder, |
||||
EVOLOCUMAB, |
||||
| 891 | 26779539 |
CA |
30 | 2 |
Ankylosing spondylitis, Migraine, Sleep disorder, General physical health deterioration, Gait disturbance, Joint swelling, Inflammation, Hyperhidrosis, Therapeutic response shortened, Off label use, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 892 | 26779675 |
IN |
62 | |
Joint swelling, Gait disturbance, Rheumatoid arthritis, |
||||
| 893 | 26779689 |
US |
||
Pain in extremity, Musculoskeletal stiffness, Gait disturbance, |
||||
DULAGLUTIDE, |
||||
| 894 | 26779790 |
US |
1 | |
Product dose omission issue, Wheelchair user, Gait disturbance, Emphysema, Accidental exposure to product, Dyspnoea, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 895 | 26780081 |
US |
2 | |
Joint dislocation, Mitochondrial cytopathy, Spinal osteoarthritis, Muscle spasms, Gait disturbance, Pain, Sciatica, Asthenia, Rash, Peripheral swelling, Deformity thorax, Pubic pain, Scoliosis, Nerve compression, Joint noise, Musculoskeletal stiffness, Inflammation, Vitamin B6 increased, Blood alkaline phosphatase decreased, Rib deformity, Blood phosphorus increased, Blood smear test abnormal, General physical health deterioration, Varicose vein, |
||||
ASFOTASE ALFA, |
||||
| 896 | 26780112 |
US |
59 | |
Illness, Gait disturbance, Vomiting, Fatigue, Rash, Dyspnoea, Pruritus, Dry skin, Eyelid oedema, Erythema, |
||||
AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE, |
||||
| 897 | 26780148 |
US |
54 | |
Gout, Gait disturbance, Joint swelling, Peripheral swelling, Rash erythematous, Pruritus, Product dose omission issue, |
||||
AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE, |
||||
| 898 | 26780530 |
US |
2 | |
Systemic lupus erythematosus, Pain in extremity, Upper limb fracture, Foot fracture, Gait disturbance, Tooth injury, Teeth brittle, Fatigue, Product dose omission issue, |
||||
ASFOTASE ALFA, |
||||
| 899 | 26780572 |
EU |
43 | 2 |
Neuropathy peripheral, Multiple sclerosis, Drug dependence, Drug ineffective, Feeling hot, Circulatory collapse, Pneumonia, Choking sensation, Muscle spasms, Bladder dysfunction, Exercise tolerance decreased, Nasopharyngitis, Thyroid mass, Musculoskeletal stiffness, Discomfort, Cystitis noninfective, Feeling hot, Hypertension, Dysmenorrhoea, Micturition urgency, Hypoaesthesia, Muscle spasticity, Toothache, Back pain, Fear of falling, Walking disability, Gait disturbance, Seasonal allergy, Blood pressure increased, Anxiety, Muscle tightness, Crying, Neuralgia, Palpitations, Nasopharyngitis, Tremor, Panic attack, Facial pain, Arthralgia, Foreign body in eye, Malaise, Initial insomnia, Nausea, Fatigue, Headache, Dizziness, Vision blurred, Burning sensation, Dysaesthesia, Abdominal discomfort, Feeling abnormal, Pain, Cardiac disorder, Accidental overdose, Flushing, Inflammatory marker increased, COVID-19, Dyspnoea, Decreased appetite, Diarrhoea, Otitis media, Tachycardia, Malaise, Micturition urgency, Burning sensation, Asthenia, |
||||
PREGABALIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, ENALAPRIL, ENALAPRIL, ENALAPRIL, SIMVASTATIN, |
||||
| 900 | 26781127 |
US |
75 | 2 |
Tremor, Gait disturbance, Tardive dyskinesia, Tardive dyskinesia, |
||||
CARIPRAZINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
